| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. is a Chief Research Officer at Travere Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sell | 12,446 | $32.87 | $409,100.02 | -10.2% | +34.3% | - | |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE | 60,000 | $40.10 | $2,406,180.00 | -37.2% | -33.5% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Research Officer | Sale+OE | 3,198 | $21.05 | $67,317.90 | -3.1% | -25.5% | +109.2% | |
| Feb 12, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sale+OE | 5,200 | $23.53 | $122,356.00 | -5.0% | -9.7% | +31.9% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 8,951 | $19.78 | $177,050.78 | -8.6% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,437 | $19.46 | $47,424.02 | -2.8% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 4,387 | $11.52 | $50,538.24 | -4.9% | +46.0% | +68.3% | |
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 4,764 | $8.71 | $41,495.10 | -2.8% | -30.2% | +137.9% | |
| Jan 23, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,062 | $8.96 | $18,475.52 | -3.3% | -37.0% | +109.5% | |
| Sep 5, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,815 | $14.71 | $26,698.65 | -2.9% | -55.7% | -29.2% |